METRO-BIBF Phase II, randomised, placebo controlled,...

METRO-BIBF Phase II, randomised, placebo controlled, multicentre, feasibility study of low dose (metronomic) cyclophosphamide (MCy) with and without nintedanib in advanced ovarian cancer (AOC)

Hall, M., Lillywhite, R., Nicum, S., Lord, R., Glasspool, R., Feeney, M., Hackshaw, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw374.51
Date:
October, 2016
File:
PDF, 38 KB
english, 2016
Conversion to is in progress
Conversion to is failed